Immune Checkpoint Inhibitor-Induced Central Diabetes Insipidus: Looking for the Needle in the Haystack or a Very Rare Side-Effect to Promptly Diagnose?

Immune checkpoint inhibitors have improved the survival in patients affected by an increasing number of malignancies, but they may also trigger various autoimmune side-effects, including endocrinopathies. Very rarely, immune checkpoint inhibitors have been reported to cause central diabetes insipidu...

Descripción completa

Detalles Bibliográficos
Autores principales: Barnabei, Agnese, Strigari, Lidia, Corsello, Andrea, Paragliola, Rosa Maria, Falzone, Luca, Salvatori, Roberto, Corsello, Salvatore Maria, Torino, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927719/
https://www.ncbi.nlm.nih.gov/pubmed/35311088
http://dx.doi.org/10.3389/fonc.2022.798517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927719/
https://www.ncbi.nlm.nih.gov/pubmed/35311088
http://dx.doi.org/10.3389/fonc.2022.798517

Ejemplares similares